Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPOR | P19235 | 4/20 | 0.49 |
| ▸ | CPB2 | Q96IY4 | 2/20 | 0.44 |
| ▸ | MEN1 | O00255 | 2/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.43 |
| ▸ | MMP2 | P08253 | 2/20 | 0.43 |
| ▸ | F2 | P00734 | 1/20 | 0.42 |
| ▸ | MC4R | P32245 | 1/20 | 0.41 |
| ▸ | MC5R | P33032 | 1/20 | 0.41 |
| ▸ | MC3R | P41968 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 1/20 | 0.41 |
| ▸ | POLB | P06746 | 1/20 | 0.41 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.41 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.41 |
| ▸ | MAOA | P21397 | 1/20 | 0.41 |
| ▸ | MMP9 | P14780 | 1/20 | 0.40 |
| ▸ | GSR | P00390 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19100377 | 1.00 | EPOR (0.49) | EPORCPB2MEN1KMT2AMMP2 | |
| SCHEMBL21461808 | 0.95 | EPOR (0.44) | EPORCPB2MEN1KMT2AMC4R | |
| SCHEMBL8465298 | 0.91 | EPOR (0.47) | EPORCPB2MEN1KMT2AMMP2 | |
| SCHEMBL1388218 | 0.89 | EPOR (0.46) | EPORCPB2MEN1KMT2AMMP2 | |
| SCHEMBL27462544 | 0.89 | EPOR (0.46) | EPORCPB2MEN1KMT2AMMP2 | |
| SCHEMBL2723861 | 0.86 | EPOR (0.59) | EPORCPB2MMP2F2MC4R | |
| SCHEMBL2723866 | 0.86 | EPOR (0.59) | EPORCPB2MMP2F2MC4R | |
| SCHEMBL7379793 | 0.86 | CPB2 (0.48) | EPORCPB2F2MC4RMC5R | |
| Lysine SCHEMBL18114001 | 0.85 | MMP2 (0.51) | CPB2KMT2AMMP2MC4RMC5R | |
| SCHEMBL30417019 | 0.85 | EPOR (0.54) | EPORCPB2ALDH1A1LMNAPOLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12610945-B2 | Stimuli-responsive polymeric nanoparticles, methods of making stimuli-responsive polymeric nanoparticles, and methods of using stimuli-responsive polymeric nanoparticles | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC. (US) | 2026-04-28 | — | — | US | disclosed |
| US-20230200382-A1 | STIMULI-RESPONSIVE POLYMERIC NANOPARTICLES, METHODS OF MAKING STIMULI-RESPONSIVE POLYMERIC NANOPARTICLES, AND METHODS OF USING STIMULI-RESPONSIVE POLYMERIC NANOPARTICLES | NATIONAL SCIENCE FOUNDATION | 2023-06-29 | — | — | US | disclosed |
| US-11627738-B2 | Stimuli-responsive polymeric nanoparticles, methods of making stimuli-responsive polymeric nanoparticles, and methods of using stimuli-responsive polymeric nanoparticles | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC. (US) | 2023-04-18 | — | — | US | disclosed |
| US-20220146518-A1 | TAG FOR LABELING BIOMOLECULES | SHANGHAI POLARIS BIOLOGY CO., LTD. (CN) | 2022-05-12 | — | — | US | disclosed |
| WO-2020228734-A1 | A TAG FOR LABELING BIOMOLECULES | SHANGHAI POLARIS BIOLOGY CO., LTD. (CN) | 2020-11-19 | — | — | WO | disclosed |
| US-20200352161-A1 | STIMULI-RESPONSIVE POLYMERIC NANOPARTICLES, METHODS OF MAKING STIMULI-RESPONSIVE POLYMERIC NANOPARTICLES, AND METHODS OF USING STIMULI-RESPONSIVE POLYMERIC NANOPARTICLES | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC. | 2020-11-12 | — | — | US | disclosed |
| WO-2017120098-A1 | STIMULI-RESPONSIVE POLYMERIC NANOPARTICLES, METHODS OF MAKING STIMULI-RESPONSIVE POLYMERIC NANOPARTICLES, AND METHODS OF USING STIMULI-RESPONSIVE POLYMERIC NANOPARTICLES | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC. (US) | 2017-07-13 | — | — | WO | disclosed |
| US-6670438-B1 | Silicatein; polypeptides | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2003-12-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220146518-A1 | TAG FOR LABELING BIOMOLECULES | BTD, DNPEP, ALB | EPOR 1080/4885CPB2 470/4885MEN1 2558/4885 |
| US-12610945-B2 | Stimuli-responsive polymeric nanoparticles, methods of making stimuli-responsive polymeric nanoparticles, and methods of using stimuli-responsive polymeric nanoparticles | CD44, STRAP, PSPH | EPOR 1849/4885CPB2 4449/4885MEN1 4045/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.